102 related articles for article (PubMed ID: 22894158)
21. Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children.
Wang LZ; Sun LR; Zhao YX; Wang LL
Int Immunopharmacol; 2011 Sep; 11(9):1211-9. PubMed ID: 21492747
[TBL] [Abstract][Full Text] [Related]
22. [Activation of NOD2 signalling pathway stimulates the function of human dendritic cells loaded with leukemia cell lysates].
Han DL; Wang HY; Guo JM; Yi H; Zeng YQ; Ai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1591-6. PubMed ID: 24370054
[TBL] [Abstract][Full Text] [Related]
23. Conditioned medium from HeLa cells enhances motility of human monocyte-derived dendritic cells but abrogates their maturation and endocytic activity.
Kúdela P; Schwarczová Z; Sedlák J; Bizik J
Neoplasma; 2001; 48(5):382-8. PubMed ID: 11845983
[TBL] [Abstract][Full Text] [Related]
24. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
[TBL] [Abstract][Full Text] [Related]
25. Interferon gamma boosts the nucleotide oligomerization domain 2-mediated signaling pathway in human dendritic cells in an X-linked inhibitor of apoptosis protein and mammalian target of rapamycin-dependent manner.
Fekete T; Koncz G; Szabo B; Gregus A; Rajnavölgyi E
Cell Mol Immunol; 2017 Apr; 14(4):380-391. PubMed ID: 26521691
[TBL] [Abstract][Full Text] [Related]
26. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
Fogler WE; Fidler IJ
Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
[TBL] [Abstract][Full Text] [Related]
27. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
28. A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth.
Fujimura T; Yamasaki K; Hidaka T; Ito Y; Aiba S
J Dermatol Sci; 2011 May; 62(2):107-15. PubMed ID: 21411292
[TBL] [Abstract][Full Text] [Related]
29. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
30. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
31. Separation of dendritic cells from highly purified human monocytes by counterflow centrifugation induces tissue factor expression.
Broussas M; Cornillet-Lefebvre P; Bernard J; Adjizian JC; Potron G; Nguyên P
Transfusion; 2000 Sep; 40(9):1088-94. PubMed ID: 10988312
[TBL] [Abstract][Full Text] [Related]
32. The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction.
Fogler WE; Fidler IJ
J Immunol; 1986 Mar; 136(6):2311-7. PubMed ID: 2936824
[TBL] [Abstract][Full Text] [Related]
33. "Meshed-Bag Gathered-Bunch" method for solid-phase synthesis of small molecular diverse compounds.
Zhang SD; Liu G; Xia SQ; Wu P; Zhang L
J Comb Chem; 2002; 4(2):131-7. PubMed ID: 11886287
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activity of conjugates of muramyl and normuramyl dipeptides with batracylin derivatives.
Dzierzbicka K; Trzonkowski P; Sewerynek P; Myśliwski A
J Med Chem; 2003 Mar; 46(6):978-86. PubMed ID: 12620074
[TBL] [Abstract][Full Text] [Related]
35. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
36. Solid-phase synthesis of muramyl dipeptide (MDP) derivatives using a multipin method.
Liu G; Zhang SD; Xia SQ; Ding ZK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1361-3. PubMed ID: 10890164
[TBL] [Abstract][Full Text] [Related]
37. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
38. Maturation of monocyte-derived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine.
Nabeshima S; Murata M; Hamada M; Chong Y; Yamaji K; Hayashi J
Int Immunopharmacol; 2004 Jan; 4(1):37-45. PubMed ID: 14975358
[TBL] [Abstract][Full Text] [Related]
39. Automated generation of immature dendritic cells in a single-use system.
Kozbial A; Bhandary L; Collier BB; Eickhoff CS; Hoft DF; Murthy SK
J Immunol Methods; 2018 Jun; 457():53-65. PubMed ID: 29625078
[TBL] [Abstract][Full Text] [Related]
40. Proteoglycans regulate the chemotaxis of dendritic cells derived from human peripheral blood monocytes.
Yoshino H; Takahashi K; Monzen S; Kashiwakura I
Biol Pharm Bull; 2010; 33(6):938-44. PubMed ID: 20522956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
